Phase II trial of individualized/dynamic cisplatin regimens for definitive concurrent chemoradiation therapy in patients with head and neck squamous cell carcinoma

The current standard cisplatin regimen for concurrent chemoradiation therapy (CCRT) involves generalized static administration of cisplatin without considering patient characteristics and patient/tumor responses during treatment. We aimed to evaluate the oncological feasibility of individualized/dyn...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Dongbin, Lee, Gil Joon, Sohn, Jin Ho, Lee, Jeong Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774729/
https://www.ncbi.nlm.nih.gov/pubmed/33073917
http://dx.doi.org/10.1002/cam4.3529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774729/
https://www.ncbi.nlm.nih.gov/pubmed/33073917
http://dx.doi.org/10.1002/cam4.3529

Ejemplares similares